- JP-listed companies
- GNI Group Ltd.
- Income statement
GNI Group Ltd. (2160) Income statement
Market cap
¥177.1B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 90 | 162 | 184 | 475 | 1,017 | 1,307 | 2,648 | 5,019 | 7,446 | 9,774 | 12,690 | 17,419 | 26,011 | 23,612 | 26,840 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | 11 | 20 | 16 | 24 | 15 | 1,051 | 1,546 | 1,600 | 2,674 | 3,579 | 5,575 | 6,847 |
| Gross profit | - | - | - | 10 | 4 | 3 | 4 | 3 | 6,395 | 8,228 | 11,090 | 14,745 | 22,431 | 18,037 | 19,993 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating expenses | - | - | - | 349 | 317 | 314 | 351 | 309 | 4,334 | 5,181 | 7,959 | 10,966 | 15,293 | 15,772 | 18,989 |
| Operating income | - | - | - | -339 | -314 | -311 | -347 | -307 | 1,302 | 1,870 | 1,625 | 1,378 | 13,109 | 1,402 | -3,471 |
| Income before tax | -464 | -485 | -782 | -286 | -670 | -385 | 137 | 365 | 1,197 | 1,806 | 1,107 | 768 | 12,613 | 238 | -4,634 |
| Pretax margin (%) | -513.5 | -299.2 | -425.7 | -60.2 | -65.9 | -29.5 | 5.2 | 7.3 | 16.1 | 18.5 | 8.7 | 4.4 | 48.5 | 1 | -17.3 |
| Provision for income taxes | - | - | - | - | - | - | - | 173 | 568 | 440 | 1,052 | 1,636 | 3,109 | 248 | 2,516 |
| Effective tax rate (%) | - | - | - | - | - | - | - | ||||||||
| Net income | -435 | -482 | -731 | -317 | -623 | -513 | -175 | -200 | 182 | 1,258 | 1,066 | 389 | 8,094 | 1,098 | -4,244 |
| Earnings per share | -4.82 | -4.85 | -7.16 | -2.82 | -5.49 | -4.51 | -1.4 | -14.82 | 4.3 | 28.96 | 22.72 | 8.19 | 169.5 | 21.96 | -80.9 |
| Diluted EPS | - | - | - | - | - | - | - | -4.94 | 4.17 | 28.04 | 22.08 | 8.11 | 165.56 | 21.15 | -80.9 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |